{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T10:12:19Z","timestamp":1655806339778},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","medical.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.mcna.2016.03.010","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:26:23Z","timestamp":1462062383000},"page":"851-868","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacologic Therapies in Pulmonology and Allergy"],"prefix":"10.1016","volume":"100","author":[{"given":"Andrew G.","family":"Ayars","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2 Suppl","key":"10.1016\/j.mcna.2016.03.010_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter","volume":"122","author":"Wallace","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.010_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1185\/030079903125003053","article-title":"Economic impact and quality-of-life burden of allergic rhinitis","volume":"20","author":"Schoenwetter","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.mcna.2016.03.010_bib3","first-page":"147","article-title":"Rhinitis: a dose of epidemiological reality","volume":"24","author":"Settipane","year":"2003","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.010_bib4","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jaci.2010.06.050","article-title":"The epidemiology of ocular and nasal allergy in the United States, 1988-1994","volume":"126","author":"Singh","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.mcna.2016.03.010_bib5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2011.09.005","article-title":"Histamine and H1-antihistamines: celebrating a century of progress","volume":"128","author":"Simons","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.mcna.2016.03.010_bib6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1398-9995.2007.01521.x","article-title":"Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis","volume":"62","author":"Rosenblut","year":"2007","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.mcna.2016.03.010_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/014556130808700812","article-title":"Epistaxis and its relationship to handedness with use of intranasal steroid spray","volume":"87","author":"Benninger","year":"2008","journal-title":"Ear Nose Throat J"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.010_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.otohns.2003.10.007","article-title":"Techniques of intranasal steroid use","volume":"130","author":"Benninger","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.010_bib9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1067\/mai.2000.106044","article-title":"Risk of cataract among users of intranasal corticosteroids","volume":"105","author":"Derby","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.010_bib10","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jaci.2005.07.031","article-title":"Discontinuing nasal steroids might lower intraocular pressure in glaucoma","volume":"116","author":"Bui","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.010_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1258\/jrsm.2008.070269","article-title":"Psychotropic drugs in the Cervantine texts","volume":"101","author":"L\u00f3pez-Mu\u00f1oz","year":"2008","journal-title":"J\u00a0R Soc Med"},{"issue":"707","key":"10.1016\/j.mcna.2016.03.010_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1749-6632.1993.tb38055.x","article-title":"Studies of the pharmacology, localization, and structure of muscarinic acetylcholine receptors","volume":"20","author":"Brann","year":"1993","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.mcna.2016.03.010_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.jhh.1001869","article-title":"The impact of oral phenylpropanolamine on blood pressure: a meta-analysis and review of the literature","volume":"19","author":"Salerno","year":"2005","journal-title":"J\u00a0Hum Hypertens"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.010_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.anorl.2014.11.001","article-title":"Benefits, limits and danger of ephedrine and pseudoephedrine as nasal decongestants","volume":"132","author":"Laccourreye","year":"2015","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"10","key":"10.1016\/j.mcna.2016.03.010_bib15","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0149-2918(99)80053-8","article-title":"Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa","volume":"21","author":"Graf","year":"1999","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.010_bib16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jaci.2011.01.037","article-title":"Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis","volume":"127","author":"Baroody","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"18","key":"10.1016\/j.mcna.2016.03.010_bib17","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"1 Suppl","key":"10.1016\/j.mcna.2016.03.010_bib18","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/0194599814561600","article-title":"Clinical practice guideline: allergic rhinitis","volume":"152","author":"Seidman","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.mcna.2016.03.010_bib19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ppul.21018","article-title":"Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions","volume":"44","author":"Bisgaard","year":"2009","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.010_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1517\/14740330902932688","article-title":"Suicidality and montelukast","volume":"8","author":"Manalai","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.mcna.2016.03.010_bib21","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1164\/ajrccm\/143.6.1334","article-title":"Airborne cat allergen (Fel d I): environmental control with the cat in\u00a0situ","volume":"143","author":"de Blay","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.mcna.2016.03.010_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1067\/mai.2003.1597","article-title":"Abatement of cockroach allergen (Bla g 1) in low-income, urban housing: a randomized controlled trial","volume":"112","author":"Arbes","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.010_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa023175","article-title":"Medical Research Council general practice research framework control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma","volume":"349","author":"Woodcock","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.mcna.2016.03.010_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001563.pub3","article-title":"House dust mite avoidance measures for perennial allergic rhinitis","author":"Sheikh","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2016.03.010_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1067\/mai.2001.117799","article-title":"Effectiveness of laundry washing agents and conditions in the removal of cat and dust mite allergen from bedding dust","volume":"108","author":"Tovey","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.010_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001936.pub2","article-title":"Allergen injection immunotherapy for seasonal allergic rhinitis","author":"Calderon","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.010_bib27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaip.2013.11.018","article-title":"Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?","volume":"2","author":"Nelson","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.010_bib28","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","article-title":"The diagnosis and management of acute and chronic urticaria: 2014 update","volume":"133","author":"Bernstein","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.010_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.anai.2011.06.008","article-title":"Utility of routine laboratory testing in management of chronic urticaria\/angioedema","volume":"107","author":"Tarbox","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10","key":"10.1016\/j.mcna.2016.03.010_bib30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.010_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.anai.2015.04.014","article-title":"Anaphylaxis and serum sickness in patients receiving omalizumab: reviewing the data in light of clinical experience","volume":"115","author":"Harrison","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.mcna.2016.03.010_bib32","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jaci.2013.03.034","article-title":"A\u00a0focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema","volume":"131","author":"Zuraw","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.mcna.2016.03.010_bib33","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","article-title":"Clinical practice. Hereditary angioedema","volume":"359","author":"Zuraw","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.010_bib34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.anai.2015.07.023","article-title":"Current treatment options for idiopathic angioedema","volume":"115","author":"Shroba","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.010_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ccm.2012.05.003","article-title":"How to diagnose and phenotype asthma","volume":"33","author":"Nair","year":"2012","journal-title":"Clin Chest Med"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.010_bib36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.mcna.2016.03.010_bib37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejim.2015.04.022","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) consensus task force recommendations for evaluation and management","volume":"26","author":"Groh","year":"2015","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.010_bib38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12931-015-0299-y","article-title":"Asthma characteristics and biomarkers from the airways disease endotyping for personalized therapeutics (ADEPT) longitudinal profiling study","volume":"16","author":"Silkoff","year":"2015","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.010_bib39","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaci.2005.08.017","article-title":"Attaining optimal asthma control: a practice parameter","volume":"116","author":"Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.010_bib40","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1124\/pr.111.004580","article-title":"Pharmacology and therapeutics of bronchodilators","volume":"64","author":"Cazzola","year":"2012","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.010_bib41","article-title":"Inhaled short acting beta2-agonist use in asthma: regular vs as needed treatment","author":"Walters","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.010_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pupt.2012.11.003","article-title":"Levalbuterol versus albuterol for acute asthma: a systematic review and meta-analysis","volume":"26","author":"Jat","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.010_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2500\/aap.2009.30.3201","article-title":"Inhaled corticosteroid therapy for patients with persistent asthma: learnings from studies of inhaled budesonide","volume":"30","author":"Chipps","year":"2009","journal-title":"Allergy Asthma Proc"},{"issue":"11","key":"10.1016\/j.mcna.2016.03.010_bib44","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.1997.03540350037030","article-title":"Inhaled steroids and the risk of hospitalization for asthma","volume":"277","author":"Donahue","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2016.03.010_bib45","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJM200010123431501","article-title":"Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group","volume":"343","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.010_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002991.pub2","article-title":"Inhaled corticosteroids for stable chronic obstructive pulmonary disease","author":"Yang","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.mcna.2016.03.010_bib47","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1183\/09031936.02.00276602","article-title":"Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler","volume":"19","author":"Johnell","year":"2002","journal-title":"Eur\u00a0Respir J"},{"issue":"7","key":"10.1016\/j.mcna.2016.03.010_bib48","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1164\/rccm.201209-1739PP","article-title":"\u03b22-agonist therapy in lung disease","volume":"187","author":"Cazzola","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.010_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1378\/chest.129.1.15","article-title":"The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol","volume":"129","author":"Nelson","year":"2006","journal-title":"Chest"},{"issue":"20","key":"10.1016\/j.mcna.2016.03.010_bib50","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","article-title":"Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group","volume":"337","author":"Pauwels","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.010_bib51","article-title":"Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma","author":"Ducharme","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.010_bib52","article-title":"Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma","author":"Greenstone","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.010_bib53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/thx.2007.081596","article-title":"Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review","volume":"63","author":"Joos","year":"2008","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.010_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJM199807163390302","article-title":"Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction","volume":"339","author":"Leff","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.mcna.2016.03.010_bib55","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/thx.52.12.1030","article-title":"Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist","volume":"52","author":"Reiss","year":"1997","journal-title":"Thorax"},{"issue":"18","key":"10.1016\/j.mcna.2016.03.010_bib56","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.010_bib57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.anai.2015.06.029","article-title":"Tiotropium for the treatment of adolescents with moderate to severe symptomatic asthma: a systematic review with meta-analysis","volume":"115","author":"Rodrigo","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.010_bib58","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.mcna.2016.03.010_bib59","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1009705","article-title":"Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children","volume":"364","author":"Busse","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2016.03.010_bib60","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-154-9-201105030-00002","article-title":"Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial","volume":"154","author":"Hanania","year":"2011","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.mcna.2016.03.010_bib61","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","article-title":"Mepolizumab for prednisone-dependent asthma with sputum eosinophilia","volume":"360","author":"Nair","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.mcna.2016.03.010_bib62","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.010_bib63","first-page":"7","article-title":"Gustatory rhinitis","volume":"48","author":"Jovancevic","year":"2010","journal-title":"Rhinology"},{"issue":"6","key":"10.1016\/j.mcna.2016.03.010_bib64","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2016.03.010_bib65","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.anai.2011.08.015","article-title":"Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial","volume":"107","author":"Lumry","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.010_bib66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaci.2011.03.006","article-title":"Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies","volume":"128","author":"Sheffer","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.010_bib67","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/cei.12379","article-title":"Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients","volume":"178","author":"Wintenberger","year":"2014","journal-title":"Clin Exp Immunol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712516000407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712516000407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T02:18:50Z","timestamp":1567822730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712516000407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0025712516000407"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2016.03.010","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic Therapies in Pulmonology and Allergy","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2016.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}